PH29938A - Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives - Google Patents

Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives

Info

Publication number
PH29938A
PH29938A PH46606A PH46606A PH29938A PH 29938 A PH29938 A PH 29938A PH 46606 A PH46606 A PH 46606A PH 46606 A PH46606 A PH 46606A PH 29938 A PH29938 A PH 29938A
Authority
PH
Philippines
Prior art keywords
hydrogen
fluorine
alkyl
5alpha
17beta
Prior art date
Application number
PH46606A
Other languages
English (en)
Inventor
Achille Panzeri
Marcella Nesi
Enrico Di Salle
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of PH29938A publication Critical patent/PH29938A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH46606A 1992-07-31 1993-07-29 Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives PH29938A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216284A GB9216284D0 (en) 1992-07-31 1992-07-31 Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives

Publications (1)

Publication Number Publication Date
PH29938A true PH29938A (en) 1996-09-16

Family

ID=10719598

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46606A PH29938A (en) 1992-07-31 1993-07-29 Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives

Country Status (28)

Country Link
US (1) US5407939A (pl)
EP (1) EP0607400B1 (pl)
JP (1) JP3325025B2 (pl)
KR (1) KR100311547B1 (pl)
CN (1) CN1041096C (pl)
AT (1) ATE159951T1 (pl)
AU (1) AU660562B2 (pl)
CA (1) CA2120343A1 (pl)
CZ (1) CZ286240B6 (pl)
DE (1) DE69315050T2 (pl)
DK (1) DK0607400T3 (pl)
ES (1) ES2110620T3 (pl)
FI (1) FI113778B (pl)
GB (1) GB9216284D0 (pl)
GR (1) GR3025546T3 (pl)
HU (2) HUT67043A (pl)
IL (1) IL106520A (pl)
MX (1) MX9304579A (pl)
MY (1) MY109633A (pl)
NO (1) NO305401B1 (pl)
NZ (1) NZ254787A (pl)
PH (1) PH29938A (pl)
PL (1) PL178591B1 (pl)
RU (1) RU2125061C1 (pl)
TW (1) TW286319B (pl)
UA (1) UA41291C2 (pl)
WO (1) WO1994003475A1 (pl)
ZA (1) ZA935481B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2158887T3 (es) * 1992-12-18 2001-09-16 Merck & Co Inc Procedimiento para tratar la prostatitis cronica con 17 beta-n-terc-butilcarbamoil-4-aza-5 alfa-androst-1-en-ona.
AU681585B2 (en) * 1993-06-24 1997-09-04 Richter Gedeon Vegyeszeti Gyar Rt. Novel process for preparing 17beta -substituted 4-azaandrostane derivatives
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
UA44257C2 (uk) * 1993-10-21 2002-02-15 Мерк Енд Ко, Інк 16-ЗАМІЩЕНІ ПОХІДНІ 4-АЗААНДРОСТАНУ, ЯК ІНГІБІТОРИ ІЗОФЕРМЕНТУ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ, СПОСІБ ІНГІБУВАННЯ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ ТА ЇЇ ІЗОФЕРМЕНТУ, СПОСІБ ЛІКУВАННЯ, СПОСІБ ПРИПИНЕННЯ ТА ОБЕРНЕННЯ АНДРОГЕННОЇ АЛОПЕЦІЇ ТА СТИМУЛЮВАННЯ РОСТУ ВОЛОССЯ У ССАВЦІВ, СПОСІБ ІНГІБУВАННЯ БІОСИНТЕТИЧНОЇ КОНВЕРСІЇ ТЕСТОСТЕРОНУ В ДИГІДРОТЕСТОСТЕРОН У ССАВЦІВ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ
GB9415178D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 4-azasteroids with side-chain fluoroketones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) * 1994-10-25 1997-01-21 Merck & Co., Inc. 7-substituted 4-aza cholanic acid derivatives and their use
IT1275594B1 (it) * 1995-07-21 1997-08-06 Pharmacia S P A Ora Pharmacia Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide
GB9518858D0 (en) * 1995-09-14 1995-11-15 Pharmacia Spa Phenylsubstituted 4-azasteroid fluoroderivatives
GB9727522D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Process for preparing carboxamido-4-azasteroids
US6645974B2 (en) * 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
NZ534946A (en) * 2002-03-13 2007-05-31 Merck & Co Inc Fluorinated 4-azasteroid derivatives as androgen receptor modulators
WO2005009949A2 (en) * 2003-06-30 2005-02-03 Merck & Co., Inc. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
AU2004255749B2 (en) 2003-06-30 2008-12-18 Merck Sharp & Dohme Corp. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
EP1641535A4 (en) * 2003-06-30 2008-05-14 Merck & Co Inc 17-ACETAMIDO-4-AZASTEROID DERIVATIVES AS ANDROGEN RECEPTOR MODULATORS
EP1641761A4 (en) * 2003-06-30 2008-05-14 Merck & Co Inc 17-ACETAMIDO-4-AZASTEROID DERIVATIVES AS ANDROGEN RECEPTOR MODULATORS
EP1670483A4 (en) 2003-09-10 2010-02-17 Merck & Co Inc 17-heterocyclic 4-azasteroid derivatives as androgen receptor modules
EP1663228A4 (en) * 2003-09-10 2010-10-06 Merck Sharp & Dohme 17-heterocyclic 4-azasteroid derivatives as androgen receptor modules
CA2562132A1 (en) * 2004-04-08 2005-10-27 Merck & Co., Inc. 17 beta-acetamide-4-azasteroids as androgen receptor modulators
BRPI0920681A2 (pt) * 2008-10-28 2015-12-29 Biomarin Pharm Inc inibidores de decahidro-1h-indenoquinolinona e decahidro-3h-ciclopentafenantridinona de cyp17
KR102541494B1 (ko) 2019-09-11 2023-06-08 주식회사 엘지화학 고흡수성 수지의 제조 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
GB9002922D0 (en) * 1990-02-09 1990-04-04 Erba Carlo Spa 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
AUPP930799A0 (en) * 1999-03-18 1999-04-15 University Of Sydney, The Optical planar waveguide device and method of its fabrication

Also Published As

Publication number Publication date
US5407939A (en) 1995-04-18
ATE159951T1 (de) 1997-11-15
CZ286240B6 (cs) 2000-02-16
HUT67043A (en) 1995-01-30
GR3025546T3 (en) 1998-03-31
AU4704893A (en) 1994-03-03
MX9304579A (es) 1994-02-28
CN1041096C (zh) 1998-12-09
ZA935481B (en) 1994-05-16
EP0607400B1 (en) 1997-11-05
DE69315050T2 (de) 1998-03-05
FI941424A0 (fi) 1994-03-28
NZ254787A (en) 1995-11-27
IL106520A (en) 1997-11-20
HU211238A9 (en) 1995-11-28
CA2120343A1 (en) 1994-02-17
JPH06511497A (ja) 1994-12-22
KR100311547B1 (ko) 2002-06-20
ES2110620T3 (es) 1998-02-16
NO305401B1 (no) 1999-05-25
CZ153893A3 (en) 1994-02-16
RU2125061C1 (ru) 1999-01-20
FI941424A7 (fi) 1994-05-27
MY109633A (en) 1997-03-31
NO941080D0 (no) 1994-03-24
GB9216284D0 (en) 1992-09-16
DK0607400T3 (da) 1998-01-26
HU9400914D0 (en) 1994-06-28
UA41291C2 (uk) 2001-09-17
PL178591B1 (pl) 2000-05-31
CN1085224A (zh) 1994-04-13
NO941080L (no) 1994-05-18
TW286319B (pl) 1996-09-21
DE69315050D1 (de) 1997-12-11
EP0607400A1 (en) 1994-07-27
FI113778B (fi) 2004-06-15
AU660562B2 (en) 1995-06-29
HK1011693A1 (en) 1999-07-16
WO1994003475A1 (en) 1994-02-17
IL106520A0 (en) 1993-11-15
JP3325025B2 (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
GB9216284D0 (en) Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
AU555323B2 (en) Esters of phosphinyl alkanoyl substituted prolines
AU5898580A (en) Pyroglutamic acid derivatives
AU596389B2 (en) 1-arylpyrazoles
DE3876813D1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
CA2003172A1 (en) Certain 2-(2&#39;,3&#39;,4&#39;-trisubstituted benzoyl)-1,3-cyclohexanediones
LU91031I2 (en) Zaxem
AU551618B2 (en) Pyridazinone derivatives
ATE386724T1 (de) Substituierte hexahydrobenzo(a) phenanthridine
EP0696585A4 (pl)
ES2102327A1 (es) Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
SG52733A1 (en) Methotrexate derivative
ES8505664A1 (es) Procedimiento para la obtencion de derivados de hidroxietilazoliloxima
ES2185237T3 (es) 1-(asamantil)amidinas y su utilizacion en el tratamiento de estados generalmente asociados con anomalias en la transmision glutamatergica.
ES8801670A1 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa pregnano.
ES2001102A6 (es) Un procedimiento para la preparacion de un derivado de indeno.
SG47940A1 (en) Light screening agent
GB2003866A (en) Thiourea derivatives
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents